JGA DL 3ML 23X25 C5 DOMPERIDONA PRINCIPIO ACTIVO: DAPAGLIFLOZINA

Description

PRINCIPIO ACTIVO: DAPAGLIFLOZINA

LIXISENATIDA

80 MG VITAMINA E 18

HEMLIBRA® 150 mg/mL es un medicamento anticuerpo monoclonal cuyo principio activo es Emicizumab

JGA DL 3ML 23X25 C5 DOMPERIDONA PRINCIPIO ACTIVO: DAPAGLIFLOZINADOSIS: 23X25 MM PRESENTACIN: 1 CAJA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy